# OnCo record paper-imbrave150-nejm-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-imbrave150-nejm-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-imbrave150-nejm-2020" ;
  schema:name "IMbrave150: atezolizumab plus bevacizumab replaces sorafenib as first treatment for advanced liver cancer"@en ;
  schema:description "Combining the immunotherapy atezolizumab with the anti-blood-vessel antibody bevacizumab helped patients with advanced hepatocellular carcinoma live longer than sorafenib, ending a decade in which nothing had beaten that drug."@en ;
  schema:url <https://onco.cc/key-papers/paper-imbrave150-nejm-2020/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1915745>, <https://clinicaltrials.gov/study/NCT03434379> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1915745> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Finn RS, Qin S, Ikeda M, et al." ;
  onco:cancers <https://onco.cc/cancers/hcc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/antiangiogenic/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/pdl1/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> ;
  onco:terms <https://onco.cc/terms/os/>, <https://onco.cc/terms/pfs/>, <https://onco.cc/terms/first-line/>, <https://onco.cc/terms/standard-of-care/> ;
  onco:people <https://onco.cc/people/kim-tae-you/>, <https://onco.cc/people/lim-ho-yeong/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-immunotherapy-response/>, <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-combination-space/> ;
  onco:journals <https://onco.cc/journals/nejm/> .